Bath Salts: Not as Harmless as They Sound

Journal of Emergency Nursing

Volumn 38, Issue 6, 2012, Pages 582-588

  McGraw, Mark ^a   McGraw, Lindsey ^a  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; CATHINONE; CENTRAL STIMULANT AGENT; DOMESTIC CHEMICAL; MONOMETHYLPROPION; PROPIOPHENONE DERIVATIVE; STREET DRUG;

ADDICTION; ADULT; ARTICLE; DRUG CONTROL; EMERGENCY; HUMAN; LEGAL ASPECT; MALE; UNITED STATES;

ADULT; ALKALOIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG AND NARCOTIC CONTROL; EMERGENCIES; HOUSEHOLD PRODUCTS; HUMANS; MALE; PROPIOPHENONES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84868370846     PISSN: 00991767     EISSN: 15272966     Source Type: Journal    
DOI: 10.1016/j.jen.2012.07.025     Document Type: Article

References (49)

1. Karunamoorthi K, Udeani G, Babu SM, Mossie A Psychopharmacosocial aspects of catha edulis forsk (fam. celastraceaw). Afr J Pharm Sci Pharm 2010, 1(1):112-129.
2. Wood DM, Davies S, Puchnarewicz M, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 2010, 6(3):327-330.
3. Toennes SW, Harder S, Schramm M, Niess C, Kauert GF Pharmacokinetics of cathinone, cathine and norepinephrine after the chewing of khat leaves. Br J Clin Pharmacol 2003, 56(1):125-130.
4. Prosser JM, Nelson LS The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2011, 8(1):33-42.
5. European Monitoring Centre for Drugs and Drug Addiction. Synthetic cathinones. EMCDDA drug profiles. Available at: Published 2011. http://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cathinones.
6. American Association of Poison Control Centers. Bath salts. Available at: Accessed June 20, 2011. http://www.aapcc.org/dnn/Portals/0/Bath%20Salts%20Data%20for%20Website%206.08.2012.pdf.
7. Penders TM How to recognize a patient who's high on "bath salts. J Fam Pract 2012, 61(4):210-212.
8. Advisory Council on the Misuse of Drugs Consideration of the Cathinones 2010, Advisory Council on the Misuse of Drugs, London, England.
9. The Vaults of Erowid. Psychoactive vaults. Available at: Accessed November 15, 2011. http://www.erowid.org/psychoactives/psychoactives.html.
10. Schifano F, Albanese A, Fergus S, et al. Mephedrone (4-methylmethcathinone; 'meow-meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011, 214(3):593-602.
11. Brunt TM, Poortman A, Niesink RJ, van den Brink W Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol 2011, 25(11):1543-1547.
12. Kavanagh PV, McNamara S, Angelov D, McDermott S, Mullan D, Ryder SA The Characterization of 'Legal Highs' Available From Head Shops in Dublin [poster] 2010, National Drug Advisory and Drug Treatment Board, Dublin, Ireland.
13. Davies S, Wood DM, Smith G, et al. Purchasing 'legal highs' on the internet-is there consistency with what you get?. QJM 2010, 103(7):489-493.
14. The Federal Analog Act, 21 USC §813 of The Comprehensive Drug Abuse Prevention and Controlled Act of 1970.
15. Rannazzisi JT, Office of Diversion Control, Drug Enforcement Administration, US Department of Justice The Dangers of Synthetic Cannabinoids and Stimulants. Statement before the Senate Caucus on International Narcotics Control 2011.
16. US Drug Enforcement Administration. Chemicals used in "bath salts" now under federal control and regulation; DEA will study whether to permanently control three substances. Available at: Accessed November 30, 2011. http://www.justice.gov/dea/pubs/pressrel/pr102111.html.
17. Schedule of controlled substances: temporary placement of three synthetic cathinones into schedule I Final order. Fed Regist 2011, 76(204):65371-65376.
18. Fass JA, Fass AD, Garcia AS Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother 2012, 46(3):426-441.
19. National Conference of State Legislatures. Substituted cathinones (a.k.a. "bath salts") enactments. Available at: Accessed June 25, 2012. http://www.ncsl.org/issues-research/justice/substituted-cathinones-enactments.aspx.
20. Cozzi NV, Sievert MK, Shulgin AT, Jacob P, Ruoho AE Inhibition of plasma membrane monoamine transporters by B-ketoamphetamines. Eur J Pharmacol 1999, 381(1):63-69.
21. Kalix P Cathinone, an alkaloid from Khat leaves with an amphetamine-like releasing effect. Psychopharmacology (Berl) 1981, 74(3):269-270.
22. Curry SC, Mills KC, Ruha A Neurotransmitters and neuromodulators. Goldfrank's Toxicological Emergencies 2008, 214-248. McGraw-Hill, New York, NY. 8th ed. M.J. Wonsiewicz, K.G. Edmonson, P.J. Boyle (Eds.).
23. Glennon RA Neurobiology of hallucinogens. The American Psychiatric Publishing Textbook of Substance Abuse Treatment 2008, 181-189. American Psychiatric Publishing, Arlington, VA. 4th ed. M. Galanter, H.D. Kleber (Eds.).
24. Kelly JP Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 2011, 3(7-8):439-453.
25. Olives TD, Orozco BS, Stellpflug SJ Bath salts: the ivory wave of trouble. West J Emerg Med 2012, 13(1):58-62.
26. Kim HS, Aftab A, Shah M, Nayar J Physical and psychological effects of the new legal high 'Ivory Wave': a case report. Br J Med Practitioners 2010, 3(4):44-46.
27. Rothman RB, Blough BE, Baumann MH Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J 2007, 9(1):E1-E10.
28. Holschneider DP, Shih JC Monoamine oxidase: basics and clinical perspectives. Psychopharmacology-The Fourth Generation of Progress 2000, Raven Press, New York, NY.
29. Boos T. Drug & chemical evaluation section (ODE). Presented at the 20th National Conference on Pharmaceutical and Chemical Diversion, June 14-15, 2011, Fort Worth, TX. Available at: Accessed November 1, 2011. http://www.deadiversion.usdoj.gov/mtgs/drug_chemical/2011/boos.pdf.
30. Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. Am J Med. In press.
31. Meyer MR, Du P, Schuster F, Maurer HH Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 2010, 45(12):1426-1442.
32. Strano-Rossi S, Cadwallader AB, de la Torre X, Botre F Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2010, 24(18):2706-2714.
33. Frohlich S, Lambe E, O'Dea J Acute liver failure following the recreational use of psychotropic "head shop" compounds. Ir J Med Sci 2011, 180(1):263-264.
34. Transmetron. Synthetic stimulants-designer stimulant information, use, testing & treatments. Available at: Published 2011. Accessed July 9, 2011. http://www.uatests.com.drug-information/synthetic-stimulants.html.
35. Dargan PI, Albert S, Wood DM Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010, 103(11):875-879.
36. Spiller HA, Ryan ML, Weston RG, Jansen J Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the united states. Clin Toxicol (Phila) 2011, 49(6):499-505.
37. Jerry J, Collins G, Streem D Synthetic legal intoxicating drugs: The emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med 2012, 79(4):258-264.
38. Nicholson PJ, Quinn MJ, Dodd JD Headshop heartache: acute mephedrone 'meow' myocarditis. Heart 2010, 96(24):2051-2052.
39. Garrett G, Sweeney M The serotonin syndrome as a result of mephedrone toxicity. BMJ Case Rep 2010, 10.1136/bcr.04.2010.2925.
40. Wood DM, Greene SL, Dargan PI Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2010, 28(4):280-282.
41. Scalzo JA Chemistry, toxicology, pharmacology, pharmacodynamics, oh my! What does this mean? I've got a patient agitated now seizing March 21, 2012, Presented at Logan College, St Louis, MO.
42. Adebamiro A, Perazella MA Recurrent acute kidney injury following bath salts intoxication. Am J Kidney Dis 2012, 59(2):273-275.
43. Stepens A, Logina I, Liguts V, et al. A parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008, 358(10):1009-1017.
44. de Bie RM, Gladstone RM, Strafella AP, Ko J, Lang AE Manganese-induced parkinsonism associated with methcathinone (ephedrone) abuse. Arch Neurol 2007, 64(6):886-889.
45. Rossander-Hulten L, Brune M, Sandstrom B, Lonnerdal B, Hallberg L Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 1991, 54(1):152-156.
46. Farrell M New drugs. Action on New Drugs 2010.
47. Coburn VA, Mycyk MB Physical and chemical restraints. Emerg Med Clin North Am 2009, 27(4):655-667.
48. Antonowicz JL, Metzger AK, Ramanujam SL Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases. Gen Hosp Psychiatry 2011, 33(6):640.e5-640.e6.
49. Penders TM, Gestring R Hallucinatory delirium following use of MDPV: "bath salts. Gen Hosp Psychiatry 2011, 33(5):525-526.